Detalhe da pesquisa
1.
Heightened Microbial Translocation Is a Prognostic Biomarker of Recurrent Tuberculosis.
Clin Infect Dis
; 75(10): 1820-1826, 2022 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35352112
2.
Plasma Chemokines Are Baseline Predictors of Unfavorable Treatment Outcomes in Pulmonary Tuberculosis.
Clin Infect Dis
; 73(9): e3419-e3427, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32766812
3.
Heterogeneity in the cytokine profile of tuberculosis - diabetes co-morbidity.
Cytokine
; 125: 154824, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31472402
4.
The recent trend in mycobacterial strain diversity among extra pulmonary lymph node tuberculosis and their association with drug resistance and the host immunological response in South India.
BMC Infect Dis
; 20(1): 894, 2020 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33243148
5.
Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co-morbidity.
Immunology
; 156(3): 249-258, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30427060
6.
Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy.
BMC Infect Dis
; 19(1): 1039, 2019 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31818258
7.
Catalytic Activities of Mono- and Bimetallic (Gold/Silver) Nanoshell-Coated Gold Nanocubes toward Catalytic Reduction of Nitroaromatics.
Langmuir
; 34(46): 13897-13904, 2018 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30365894
8.
Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment.
BMC Infect Dis
; 18(1): 345, 2018 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-30045688
9.
Chitinase and indoleamine 2, 3-dioxygenase are prognostic biomarkers for unfavorable treatment outcomes in pulmonary tuberculosis.
Front Immunol
; 14: 1093640, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36814914
10.
Effect of anti-tuberculosis treatment on the systemic levels of tissue inhibitors of metalloproteinases in tuberculosis - Diabetes co-morbidity.
J Clin Tuberc Other Mycobact Dis
; 23: 100237, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33997311
11.
Acute Phase Proteins Are Baseline Predictors of Tuberculosis Treatment Failure.
Front Immunol
; 12: 731878, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34867953
12.
Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.
JAMA Netw Open
; 3(12): e2027754, 2020 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33258908
13.
Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis.
Sci Rep
; 9(1): 18217, 2019 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31796883
14.
Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors.
J Infect
; 74(1): 10-21, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27717783
15.
Heightened circulating levels of antimicrobial peptides in tuberculosis-Diabetes co-morbidity and reversal upon treatment.
PLoS One
; 12(9): e0184753, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28910369
16.
Systems Immunology of Diabetes-Tuberculosis Comorbidity Reveals Signatures of Disease Complications.
Sci Rep
; 7(1): 1999, 2017 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28515464
17.
Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatment.
Tuberculosis (Edinb)
; 101: 191-200, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27865391
18.
Polymorphism in the RD1 locus and its effect on downstream genes among South Indian clinical isolates of Mycobacterium tuberculosis.
J Med Microbiol
; 61(Pt 10): 1352-1359, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22723257